About this trial
Familial Mediterranean fever (FMF) affect liver and causes some dysfunctions including non-alcoholic fatty liver.. still exercise and diet limitation is the treatment for this case
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
familial Mediterrean fever women
obese women
women who have fatty live (non alcoholic type)
Disqualifiers
cardiac patients
respiratory disease
renal disease
cancer
Trial design
Parallel
Treatments tested in this trial
exercise plus diet restriction
BehavioralFamilial Mediterranean fever (FMF women ) will be collected in this group. the group OF FMF will contain 20 FMF women. the group will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months. also, this group, Group I, will also perform elliptical aerobic exercise (this exercise will be applied for 40 minutes three times weekly and this exercise will be maintained for 6 months)
diet restriction
BehavioralFamilial Mediterranean fever (FMF women ) will be collected in this group. the group OF FMF will contain 20 FMF women. the group will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months.
Treatment groups
Trial outcomes
Primary outcomes
aspartate transaminase
it is a hepatic enzyme
Secondary outcomes
alanine transaminase
it is a hepatic enzyme
body mass index
it will be measured after patient emptying his bowel and bladder
waist circumference
it will be measured at umbilical level
high density lipoprotein
it will be measured in plasma
Sponsors and contacts
Click on the lead sponsor to view all of their trials.